Reboxetine

Reboxetine, sold under the brand name Edronax among others, is a drug of the norepinephrine reuptake inhibitor (NRI) class, marketed as an antidepressant by Pfizer for use in the treatment of major depression, although it has also been used off-label for panic disorder and attention deficit hyperactivity disorder (ADHD).[3] It is approved for use in many countries worldwide, but has not been approved for use in the United States. Although its effectiveness as an antidepressant... [wikipedia]